Neurogene (NGNE)
Builds a single gene therapy for Rett syndrome using a proprietary expression-control platform.
$33.68
After hours+0.10 (+0.30%)
At close$33.58(+3.10%)
Something off on this page? Send us feedback.
Next report
Nov 12, 26
estimated · in 51 days
EPS estimate
−$1.39
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.99−$1.08−$1.05−$0.99−$1.12−$1.39−$1.53Pending
Estimate−$1.04−$1.05−$1.15−$1.26−$1.24−$1.30−$1.42−$1.39
Surprise+4.8%−2.9%+8.7%+21.4%+9.6%−7.2%−7.7%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$1.75 | — | — |
| Sep 2027 | −$1.41 | — | — |
| Jun 2027 | −$1.29 | — | — |
| Mar 2027 | −$1.31 | — | — |
| Dec 2026 | −$1.32 | — | — |
| Nov 2026 | −$1.39 | — | — |
| Aug 2026 | −$1.42 | −$1.53 | −7.7% |
| May 2026 | −$1.30 | −$1.39 | −7.2% |
| Mar 2026 | −$1.24 | −$1.12 | +9.6% |
| Nov 2025 | −$1.26 | −$0.99 | +21.4% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Dec 2022 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$1.75 | — | — | $0 | — | — | — |
| Sep 2027 | −$1.41 | — | — | $0 | — | — | — |
| Jun 2027 | −$1.29 | — | — | $0 | — | — | — |
| Mar 2027 | −$1.31 | — | — | $0 | — | — | — |
| Dec 2026 | −$1.32 | — | — | $0 | — | — | — |
| Nov 12, 2026 | −$1.39 | — | — | $0 | — | — | — |
| Aug 11, 2026 | −$1.42 | −$1.53 | −7.7% | — | — | — | −2.1% |
| May 12, 2026 | −$1.30 | −$1.39 | −7.2% | — | — | — | +2.1% |
| Mar 24, 2026 | −$1.24 | −$1.12 | +9.6% | — | — | — | +8.0% |
| Nov 14, 2025 | −$1.26 | −$0.99 | +21.4% | — | — | — | −1.4% |
| Aug 11, 2025 | |||||||
| May 9, 2025 | |||||||
| Mar 24, 2025 | |||||||
| Nov 18, 2024 | |||||||
| Aug 9, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 18, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 8, 2023 | |||||||
| Mar 20, 2023 | |||||||
| Dec 30, 2022 | |||||||
| Nov 14, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 9, 2022 | |||||||
| Dec 30, 2021 | |||||||
| Sep 29, 2021 | |||||||
| Jun 29, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Sep 30, 2016 |